Nephros Announces FDA 510(k) Submission of DSU-H and SSU-H Ultrafilters to be used to filter EPA quality drinking water to remove microbiological contaminants and waterborne pathogens

Nephros Announces FDA 510(k) Submission of DSU-H and SSU-H Ultrafilters to be used to filter EPA quality drinking water to remove microbiological contaminants and waterborne pathogens

Jun 30, 2014 16:05:00 (ET)

RIVER EDGE, N.J., June 30, 2014 /PRNewswire/ — Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today that it has submitted to the U.S. Food and Drug Administration (FDA), for 510(k) clearance, the DSU-H and SSU-H Ultrafilters to filter Environmental Protection Agency (EPA) quality drinking water to remove microbiological contaminants and waterborne pathogens.

“The FDA submission of the DSU-H and SSU-H is another important step toward Nephros’s commitment to be recognized as a global leader in providing high performance liquid purification filters,” commented John C. Houghton, President and CEO of Nephros. “By providing ultrapure water for patient washing and drinking, the filters will assist in infection control.”

About Nephros, Inc.

Nephros is a commercial stage medical device company that develops and sells high performance liquid purification filters. Our filters, which we call ultrafilters, are primarily used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and/or blood.

We were founded in 1997 by healthcare professionals affiliated with Columbia University Medical Center/New York-Presbyterian Hospital to develop and commercialize an alternative method to hemodialysis (HD). We have extended our filtration technologies to meet the demand for liquid purification in other areas, in particular water purification.

Presently, we offer ultrafilters for sale to customers in four markets:

— Dialysis Centers – Water/Bicarbonate: Filtration of water or bicarbonate
concentrate used in hemodialysis devices

— Dialysis Centers – Blood: Clearance of toxins from blood using an
alternative method to HD in patients with chronic renal failure

— Military and Outdoor Recreation: Highly compact, individual water
purification devices used by soldiers and backpackers to produce drinking
water in the field

— Commercial Facilities including Hospitals: Filtration of water for
drinking and washing

For more information about Nephros, please visit the company’s website at www.nephros.com.

SOURCE Nephros, Inc.

/CONTACT: Eileen Sukumaran, 201.343.5202 ext 100

/Web site: http://www.nephros.com